Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2023 | Exploring the potential role of amyloid deposition in the gut in Alzheimer’s disease

Giovanni Frisoni • 30 Mar 2023
AD/PD 2023
Alzheimer’s Disease Dementia

Giovanni Frisoni, MD, University of Geneva, Geneva, Switzerland, discusses how amyloid deposition in the gut may play a role in the development of Alzheimer’s disease (AD). Research in Parkinson’s disease (PD) has demonstrated that alpha-synuclein may develop in the gut and spread to the brain, and it is hypothesized that a similar process may occur in AD. Prof. Frisoni explains that certain bacteria in the gut may contribute to aberrant amyloid deposition in the gastrointestinal tract, which is being further researched. This interview took place at the AD/PD™ 2023 congress in Gothenburg, Sweden.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Giovanni Frisoni

Best outcome measures for Alzheimer’s disease follow-up in the clinic
1:56
Best outcome measures for Alzheimer’s disease follow-up in the clinic
Giovanni Frisoni • 30 Mar 2023
Defining subgroups of patients with subjective cognitive decline more likely to progress
4:20
Defining subgroups of patients with subjective cognitive decline more likely to progress
Giovanni Frisoni • 30 Mar 2023
European task force recommendations: shifting memory clinics towards prevention
4:51
European task force recommendations: shifting memory clinics towards prevention
Giovanni Frisoni • 30 Mar 2023
Reframing the way we think about Alzheimer’s disease
3:28
Reframing the way we think about Alzheimer’s disease
Giovanni Frisoni • 11 Mar 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals